Delivery Order SPE2DB20D3103-SPE2DB24FN8S0

Award Date 5/17/24
Potential Completion Date 5/20/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,391.88 firm fixed-price delivery order is for the supply of 4,564,221,987 units of the generic medication Ondansetron ODT 4 mg tablets. The IDC has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical...
This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract has a ceiling value of $5,614.72 and is for the delivery of Ondansetron ODT 4 mg tablets. The IDC with DLA Troop Support Medical is valued up to $999,999,999 through December 2025 and is used by the agency to efficiently procure a comprehensive range of medical...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,404.05 and is for the delivery of Ondansetron ODT 4 mg tablets. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order, valued at $2,689.99, is for the supply of 4,564,166,999 units of Ondansetron ODT 4 mg tablet 30s....
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The order is for 4,561,076,878 units of the prescription drug Ondansetron ODT 4 mg Tablet, at a ceiling value of $1,041.90. The contract is a firm fixed-price delivery order with a completion date of May 31, 2023. The contract award was not designated with a set-aside....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,311.45, is for the delivery of Ondansetron ODT 4 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,077.84 award is for the delivery of 4563830264, which is described as ondansetron ODT 8 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of 4560732432 - Ondansetron ODT 4 mg tablets in 30-count packages, with a ceiling value of $3,198.00 and a completion date of April 27, 2023. This delivery order is part of a broader IDC that provides a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 8 mg tablets. The $1,295.75 firm fixed-price contract has a period of performance through May 16, 2024 and does not utilize any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ondansetron ODT 4 mg tablets for a total ceiling value of $5,488.01. The order has a firm fixed price and an ultimate completion date of August 27, 2024. AmerisourceBergen has a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for providing a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FN8S0
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,593.49 firm fixed price delivery order is for the supply of 4,564,639,891 Ondansetron ODT 8 mg tablets. This supports the DLA's procurement of pharmaceutical products and medical supplies for military healthcare programs. The IDC with AmerisourceBergen, valued at $999,999,999, serves as a comprehensive vehicle to provide a range of medications, vaccines, syringes, and other medical commodities across various therapeutic areas. This delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 for similar medical products and prescription drugs.

Generated 2/27/25, 9:46 AM